SpyGlass Pharma, Inc. SEC filings SGP

SpyGlass Pharma, Inc. has 92 filings in SEC EDGAR's recent list, going back to Jun 5, 2019. Its latest annual report, Form 10-K, was filed on Mar 26, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 6, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 19, 2026 (other events). The company's fiscal year ends on December 31.

Form Description Filed Period
8-K Current report
Other events
 Oct 19, 2026 Oct 19, 2026
8-K Current report
Regulation FD disclosure, Other events
 Oct 1, 2026 Oct 1, 2026
8-K Current report
Results of operations
 Aug 6, 2026 Aug 6, 2026
8-K Current report
Results of operations
 May 14, 2026 May 14, 2026
8-K Current report
Results of operations
 Mar 26, 2026 Mar 26, 2026
8-K Current report
Other events
 Mar 9, 2026 Mar 9, 2026
8-K Current report
Officer or director change
 Feb 13, 2026 Feb 12, 2026
8-K Current report
Officer or director change, Bylaw or fiscal year change, Regulation FD disclosure
 Feb 9, 2026 Feb 5, 2026

Showing 8 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Surgical & Medical Instruments & Apparatus (SIC 3841)
Listed as
SGP (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Irvine, CA
SEC filer status
, Emerging growth company
SEC CIK
1778922
Former names
SpyGlassPharma, Inc. (until Jun 5, 2025); SpyGlass Ophthalmics, Inc. (until Jan 5, 2021)

Other Surgical & Medical Instruments & Apparatus companies

All 151 Surgical & Medical Instruments & Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.